Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment

Multiple findings underline a link between altered brain cholesterol metabolism and Alzheimer's disease (AD) pathogenesis. Physiologically, excess brain cholesterol is mainly converted into 24-hydroxycholesterol (24-OHC) by the neuron-specific enzyme CYP46A1. Of note, we previously observed in...

書誌詳細
出版年:	Neurobiology of Disease
主要な著者:	Serena Giannelli, Francesca Eroli, Raúl Loera-Valencia, Valerio Leoni, Maria Latorre-Leal, Gabriella Testa, Erica Staurenghi, Barbara Sottero, Paola Gamba, Silvia Maioli, Gabriella Leonarduzzi
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2025-10-01
主題:	24-hydroxycholesterol CYP46A1 Tau hyperphosphorylation Tau oligomers Dendritic arborization Alzheimer's disease
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S0969996125002451

類似資料

24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1/PGC1α/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer’s Disease
著者:: Gabriella Testa, 等
出版事項: (2023-03-01)

The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
著者:: Paola Gamba, 等
出版事項: (2021-05-01)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
著者:: Jin Miao, 等
出版事項: (2019-03-01)

Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
著者:: Eun Ji Gong, 等
出版事項: (2011-11-01)

Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
著者:: Mei Wang, 等
出版事項: (2024-12-01)

Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment
著者:: Dantao Peng, 等
出版事項: (2013-11-01)

Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer’s diseases
著者:: Sookhee Bang, 等
出版事項: (2024-12-01)

Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau
著者:: C. F. de Veij Mestdagh, 等
出版事項: (2024-06-01)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
著者:: Amelia D. Hines, 等
出版事項: (2023-04-01)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
著者:: Yan Zhou, 等
出版事項: (2018-02-01)

Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition
著者:: Layal Abou Assi, 等
出版事項: (2024-07-01)

Adeno-Associated Viral Gene Delivery of Wild-Type Human Tau Induces Progressive Hyperphosphorylation and Neuronal Cell Death in the Hippocampi of Middle-Aged Rats
著者:: Ryan C. Gorzek, 等
出版事項: (2025-08-01)

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
著者:: Yue Dong, 等
出版事項: (2022-08-01)

Targeting Tau to Treat Clinical Features of Huntington's Disease
著者:: Maria Masnata, 等
出版事項: (2020-11-01)

DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders
著者:: Ravindran Kumaran, 等
出版事項: (2007-10-01)

Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer’s disease model mice
著者:: Dongping Yao, 等
出版事項: (2024-06-01)

Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
著者:: Rahma Hassan-Abdi, 等
出版事項: (2019-11-01)

A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
著者:: Zhouquan Jiang, 等
出版事項: (2024-01-01)

Structural Analysis and Conformational Dynamics of Short Helical Hyperphosphorylated Segments of Tau Protein (Sequence 254–290) in Alzheimer’s Disease: A Molecular Dynamics Simulation Study
著者:: Mozhgan Alipour, 等
出版事項: (2022-08-01)

A new pathway for neuroprotection against tau hyperphosphorylation via δ-opioid receptor initiated inhibition of CDK5 and AMPK signaling
著者:: Jiahui Li, 等
出版事項: (2025-06-01)

A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau
著者:: Yang Gao, 等
出版事項: (2023-11-01)

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
著者:: Shweta Kishor Sonawane, 等
出版事項: (2021-02-01)

Tau Oligomers Resist Phase Separation
著者:: Lathan Lucas, 等
出版事項: (2025-02-01)

A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence
著者:: Yoshiyuki Soeda, 等
出版事項: (2024-07-01)

Toxoplasma GRA16 attenuates Tau hyperphosphorylation and enhances autophagy in thrombin-treated HT-22 hippocampal neuronal cells
著者:: Seung-Hwan Seo, 等
出版事項: (2025-05-01)

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
著者:: John David Eun, 等
出版事項: (2022-07-01)

Novel Insights of Lithium Chloride Therapeutic Approach for Managing Type 2 Diabetic Kidney Disease: Crosslinking Tau Hyperphosphorylation and TGF Beta Signaling
著者:: Layal Abou Assi, 等
出版事項: (2025-04-01)

The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer’s Disease
著者:: Yan H, 等
出版事項: (2023-11-01)

Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
著者:: Mei Wang, 等
出版事項: (2025-02-01)

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
著者:: Huazhang Zhu, 等
出版事項: (2018-11-01)

Tau Amyloid Corona‐Shelled Nanoparticle‐Based Drug Screening Platform for Discovering Tau Oligomer‐Degrading Drugs
著者:: Hyo Gi Jung, 等
出版事項: (2025-10-01)

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models
著者:: Yulian Zou, 等
出版事項: (2021-12-01)

Curcuminoids and resveratrol as anti-Alzheimer agents
著者:: Oliver B. Villaflores, 等
出版事項: (2012-12-01)

Expression profiles of the Tau-associated genes GSk3β, CAPN1, and CDK5R1 in the brain cortex of aged female cynomolgus monkeys with cognitive impairment
著者:: Huda S. Darusman, 等
出版事項: (2025-03-01)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
著者:: Jangampalli Adi Pradeepkiran, 等
出版事項: (2019-03-01)

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
著者:: Sha Sha, 等
出版事項: (2026-02-01)

DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
著者:: Sha Sha, 等
出版事項: (2022-01-01)

Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches
著者:: Emily Hill, 等
出版事項: (2020-08-01)

Neuroprotective effects and mechanisms of osteocalcin in an Alzheimer’s disease cell model
著者:: FANG Lilin, 等
出版事項: (2025-08-01)

Porphyromonas gingivalis-induced periodontitis promotes neuroinflammation and neuronal loss associated with dysfunction of the brain barrier
著者:: Yiting Jiang, 等
出版事項: (2025-06-01)